Please assess the completion status of the following clinical trial:

Trial Title: A Safety Study of 3 Different Bowel Cleansing Preparations

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female outpatients who are undergoing colonoscopy for a routinely accepted indication.~* At least 18 years of age~* If female, and of child-bearing potential, is using an acceptable form of birth control~* Negative urine pregnancy test at screening, if applicable~* In the Investigator's judgment, subject is mentally competent to provide informed consent to participate in the study~Exclusion Criteria:~* Subjects with known or suspected ileus, severe ulcerative colitis, gastrointestinal obstruction, gastric retention, bowel perforation, toxic colitis or megacolon.~* Subjects who had previous significant gastrointestinal surgeries.~* Subjects who have uncontrolled clinically significant pre-existing electrolyte disturbances.~* Subjects with severe liver or renal insufficiency.~* Subjects with a history of congestive heart failure or other clinically significant cardiac abnormality.~* Subjects with impaired consciousness that predisposes them to pulmonary aspiration.~* Subjects undergoing colonoscopy for foreign body removal and decompression.~* Subjects who are pregnant or lactating, or intending to become pregnant during the study.~* Subjects of childbearing potential who refuse a pregnancy test.~* Subjects allergic to any preparation components~* Subjects who, in the opinion of the Investigator, should not be included in the study for any reason, including inability to follow study procedures.~* Subjects who have participated in an investigational surgical, drug, or device study within the past 30 days.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- BLI800 approved preparation regimen (Type: EXPERIMENTAL): BLI800 approved preparation regimen
- BLI800 investigational preparation regimen (Type: EXPERIMENTAL): BLI800 investigational preparation regimen
- PEG-3350 based bowel preparation (Type: ACTIVE_COMPARATOR): PEG-3350 based bowel preparation

Based on this trial design, predict the completion outcome and termination type (if applicable).